InvestorsObserver
×
News Home

Is it Time to Dump Quoin Pharmaceuticals Ltd - ADR (QNRX) Stock After it Has Risen 10.64% in a Week?

Friday, March 24, 2023 02:45 PM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump Quoin Pharmaceuticals Ltd - ADR (QNRX) Stock After it Has Risen 10.64% in a Week?

The market has been neutral on Quoin Pharmaceuticals Ltd - ADR (QNRX) stock recently. QNRX gets a Neutral score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,neutral
Quoin Pharmaceuticals Ltd - ADR has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on QNRX!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With QNRX Stock Today?

Quoin Pharmaceuticals Ltd - ADR (QNRX) stock is unmoved 0.06% while the S&P 500 has risen 0.37% as of 2:35 PM on Friday, Mar 24. QNRX is unmoved $0.00 from the previous closing price of $0.52 on volume of 114,550 shares. Over the past year the S&P 500 is down -11.06% while QNRX is down -97.33%. QNRX lost -$1.95 per share in the over the last 12 months. To screen for more stocks like Quoin Pharmaceuticals Ltd - ADR click here.

More About Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. Click Here to get the full Stock Report for Quoin Pharmaceuticals Ltd - ADR stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App